1,5-Anhydrosorbitol

From NuGOwiki

Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

1,5-Anhydrosorbitol
2D structure for 1,5-Anhydrosorbitol
Chemical Name (2R,3R,4R,5S)-2-(hydroxymethyl)oxane-3,4,5-triol
Chemical Formula C6H12O5
CAS Number 154-58-5
Chemical Information HMDB02712
Biochemical Taxonomy Not Available
Functional Taxonomy Not Available
Nutritional Taxonomy

  • Carbohydrates

Metabolic Pathways Not Available
Biofluid Location

  • Blood
  • Cerebrospinal Fluid (CSF)

Tissue Location Not Available
Normal Biofluid Concentrations

  • Blood: 130.0 (95.0 - 178.0) uM
  • Blood: 150.0 (140 - 171) uM
  • Blood: 150.0 (73.0 - 243.0) umol/L
  • Cerebrospinal Fluid (CSF): 124.6 +/- 34.2 uM
  • Cerebrospinal Fluid (CSF): 18.2 +/- 5.0 umol/L
  • Cerebrospinal Fluid (CSF): 25.0 +/- 13.0 uM
  • Cerebrospinal Fluid (CSF): 53.0 (11.0-95.0) uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Adolescents with type 1 diabetes mellitus
  • Alzheimer
  • Type 1 diabetes mellitus
  • Type 2 diabetes mellitus

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Blood (Adolescents with type 1 diabetes mellitus): 30.0 (9.7 - 66.4) uM
  • Blood (Type 1 diabetes mellitus): 50.0 (18.5 - 95.0) uM
  • Blood (Type 2 diabetes mellitus): 62.0 +/- 38.0 uM
  • Cerebrospinal Fluid (CSF) (Alzheimer): 41.7 +/-13.7 uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
1,5-anhydroglucitol (1,5-AG) is a validated marker of short-term glycemic control. This substance is derived mainly from food, is well absorbed in the intestine, and is distributed to all organs and tissues. It is metabolically stable, being excreted in the urine when its level exceeds the renal threshold. It is reabsorbed in the renal tubules, and is competitively inhibited by glucosuria, which leads to a reduction in its level in serum. The correlation between this reduction and the amount of glucose present in urine is so close that 1,5 AG can be used as a sensitive, day-to-day, real-time marker of glycemic control. It provides useful information on current glycemic control and is superior to both hemoglobin A1C and fructosamine in detecting near-normoglycemia. 1,5-AG in human plasma has been proposed for several years as a short-term, retrospective marker of glycaemic control and seems to be the most suitable parameter for monitoring glucose excursions. The decrease in serum 1,5-AG is very sensitive to urinary glucose excretion. It is a metabolically inert polyol that competes with glucose for reabsorption in the kidneys. Otherwise stable levels of 1,5-AG are rapidly depleted as blood glucose levels exceed the renal threshold for glucosuria. 1,5-AG is also more tightly associated with glucose fluctuations and postprandial glucose. (PMID: 18088226, 12166605, 7783360, 8940824)

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Adolescents with type 1 diabetes mellitus
  • Alzheimer
  • Type 1 diabetes mellitus
  • Type 2 diabetes mellitus

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines